VIVUS, Inc. (Nasdaq: VVUS) plans to announce the results from the avanafil REVIVE (TA-301) phase 3 clinical trial on November 18th prior to market open. The announcement will be followed by a webcast and conference call at 8:30 a.m. Eastern time. Conference Call Information Domestic callers: 1-800-776-0853. International callers: 1-913-312-0980.

Tenneco Inc. (NYSE: TEN) today announced its intention to offer 10,000,000 shares of its common stock pursuant to an underwritten registered public offering. In connection with the offering, Tenneco intends to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of its common stock to cover over-allotments, if any.

Emergency Medical Services Corporation (NYSE: EMS) today announced that it intends to commence a public secondary offering of 6,000,000 shares of class A common stock.